Structure

Physi-Chem Properties

Molecular Weight:  280.11
Volume:  274.974
LogP:  0.757
LogD:  0.832
LogS:  -2.535
# Rotatable Bonds:  8
TPSA:  104.73
# H-Bond Aceptor:  7
# H-Bond Donor:  3
# Rings:  1
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.758
Synthetic Accessibility Score:  2.368
Fsp3:  0.308
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.728
MDCK Permeability:  2.9252414606162347e-05
Pgp-inhibitor:  0.0
Pgp-substrate:  0.734
Human Intestinal Absorption (HIA):  0.037
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.182

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.874
Plasma Protein Binding (PPB):  33.550086975097656%
Volume Distribution (VD):  0.232
Pgp-substrate:  64.46192932128906%

ADMET: Metabolism

CYP1A2-inhibitor:  0.014
CYP1A2-substrate:  0.099
CYP2C19-inhibitor:  0.057
CYP2C19-substrate:  0.079
CYP2C9-inhibitor:  0.011
CYP2C9-substrate:  0.802
CYP2D6-inhibitor:  0.008
CYP2D6-substrate:  0.157
CYP3A4-inhibitor:  0.011
CYP3A4-substrate:  0.086

ADMET: Excretion

Clearance (CL):  1.374
Half-life (T1/2):  0.875

ADMET: Toxicity

hERG Blockers:  0.014
Human Hepatotoxicity (H-HT):  0.168
Drug-inuced Liver Injury (DILI):  0.954
AMES Toxicity:  0.021
Rat Oral Acute Toxicity:  0.008
Maximum Recommended Daily Dose:  0.006
Skin Sensitization:  0.09
Carcinogencity:  0.05
Eye Corrosion:  0.003
Eye Irritation:  0.03
Respiratory Toxicity:  0.013

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC287358

Natural Product ID:  NPC287358
Common Name*:   Giganticine
IUPAC Name:   (2S)-2-acetamido-2-[4-(ethoxycarbonylamino)phenyl]acetic acid
Synonyms:   Giganticine
Standard InCHIKey:  LXZCEJOKBHKJLM-NSHDSACASA-N
Standard InCHI:  InChI=1S/C13H16N2O5/c1-3-20-13(19)15-10-6-4-9(5-7-10)11(12(17)18)14-8(2)16/h4-7,11H,3H2,1-2H3,(H,14,16)(H,15,19)(H,17,18)/t11-/m0/s1
SMILES:  CCOC(=O)Nc1ccc(cc1)[C@@H](C(=O)O)N=C(O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL477129
PubChem CID:   10850332
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0000265] Carboxylic acids and derivatives
        • [CHEMONTID:0000013] Amino acids, peptides, and analogues
          • [CHEMONTID:0000347] Amino acids and derivatives
            • [CHEMONTID:0000060] Alpha amino acids and derivatives
              • [CHEMONTID:0001189] N-acyl-alpha amino acids and derivatives
                • [CHEMONTID:0002402] N-acyl-alpha amino acids
                  • [CHEMONTID:0004148] N-acyl-L-alpha-amino acids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30295 Calotropis gigantea Species Apocynaceae Eukaryota leaves n.a. n.a. PMID[16933890]
NPO30295 Calotropis gigantea Species Apocynaceae Eukaryota n.a. root n.a. PMID[19052526]
NPO30295 Calotropis gigantea Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[28817274]
NPO30295 Calotropis gigantea Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[31967821]
NPO30295 Calotropis gigantea Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[32649211]
NPO30295 Calotropis gigantea Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[9548837]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT3772 Organism Schistocerca gregaria Schistocerca gregaria Activity = 80.0 % PMID[494326]
NPT3772 Organism Schistocerca gregaria Schistocerca gregaria Activity = 90.0 % PMID[494326]
NPT3772 Organism Schistocerca gregaria Schistocerca gregaria Activity = 68.0 % PMID[494326]
NPT3772 Organism Schistocerca gregaria Schistocerca gregaria Activity = 55.0 % PMID[494326]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC287358 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7568 Intermediate Similarity NPC472241
0.7533 Intermediate Similarity NPC472242
0.75 Intermediate Similarity NPC474926
0.7483 Intermediate Similarity NPC478039
0.7432 Intermediate Similarity NPC472243
0.7407 Intermediate Similarity NPC197470
0.7383 Intermediate Similarity NPC43477
0.7351 Intermediate Similarity NPC314186
0.7329 Intermediate Similarity NPC253476
0.7324 Intermediate Similarity NPC322433
0.7315 Intermediate Similarity NPC242933
0.7313 Intermediate Similarity NPC474584
0.7287 Intermediate Similarity NPC164859
0.7254 Intermediate Similarity NPC205946
0.7252 Intermediate Similarity NPC327481
0.7241 Intermediate Similarity NPC314098
0.7239 Intermediate Similarity NPC329011
0.7205 Intermediate Similarity NPC189116
0.7188 Intermediate Similarity NPC12730
0.7179 Intermediate Similarity NPC314223
0.7172 Intermediate Similarity NPC314431
0.7164 Intermediate Similarity NPC319579
0.7162 Intermediate Similarity NPC173295
0.7153 Intermediate Similarity NPC58827
0.7153 Intermediate Similarity NPC307437
0.7153 Intermediate Similarity NPC72473
0.7143 Intermediate Similarity NPC259678
0.7133 Intermediate Similarity NPC319645
0.7055 Intermediate Similarity NPC472245
0.705 Intermediate Similarity NPC169328
0.7045 Intermediate Similarity NPC476198
0.7045 Intermediate Similarity NPC67043
0.7039 Intermediate Similarity NPC316202
0.7006 Intermediate Similarity NPC248862
0.7 Intermediate Similarity NPC314992
0.7 Intermediate Similarity NPC310467
0.6993 Remote Similarity NPC35996
0.6986 Remote Similarity NPC150863
0.6978 Remote Similarity NPC2265
0.6966 Remote Similarity NPC477937
0.6948 Remote Similarity NPC314287
0.6944 Remote Similarity NPC317758
0.6923 Remote Similarity NPC14849
0.6905 Remote Similarity NPC328611
0.6901 Remote Similarity NPC150323
0.6899 Remote Similarity NPC122493
0.6899 Remote Similarity NPC10781
0.6899 Remote Similarity NPC293628
0.6897 Remote Similarity NPC4974
0.6897 Remote Similarity NPC470343
0.6897 Remote Similarity NPC472244
0.6882 Remote Similarity NPC182057
0.6882 Remote Similarity NPC131450
0.6882 Remote Similarity NPC147298
0.6867 Remote Similarity NPC470971
0.6835 Remote Similarity NPC300596
0.6835 Remote Similarity NPC237649
0.6824 Remote Similarity NPC280807
0.6821 Remote Similarity NPC314835
0.6805 Remote Similarity NPC13367
0.6797 Remote Similarity NPC181527
0.6783 Remote Similarity NPC80150
0.6783 Remote Similarity NPC190663
0.6781 Remote Similarity NPC47667
0.6772 Remote Similarity NPC254798
0.6769 Remote Similarity NPC324569
0.6768 Remote Similarity NPC143457
0.6768 Remote Similarity NPC68650
0.6768 Remote Similarity NPC472102
0.6768 Remote Similarity NPC309531
0.6763 Remote Similarity NPC57051
0.6761 Remote Similarity NPC229353
0.6761 Remote Similarity NPC237420
0.6748 Remote Similarity NPC153694
0.6748 Remote Similarity NPC211525
0.6743 Remote Similarity NPC282092
0.6733 Remote Similarity NPC476689
0.6733 Remote Similarity NPC476687
0.6733 Remote Similarity NPC476685
0.6732 Remote Similarity NPC132636
0.6727 Remote Similarity NPC176983
0.6727 Remote Similarity NPC286871
0.6712 Remote Similarity NPC226794
0.6711 Remote Similarity NPC194562
0.6707 Remote Similarity NPC148468
0.6707 Remote Similarity NPC243673
0.6707 Remote Similarity NPC36495
0.6707 Remote Similarity NPC63210
0.6707 Remote Similarity NPC310403
0.6707 Remote Similarity NPC263709
0.6707 Remote Similarity NPC182131
0.6707 Remote Similarity NPC97380
0.669 Remote Similarity NPC160493
0.669 Remote Similarity NPC27581
0.6688 Remote Similarity NPC315224
0.6667 Remote Similarity NPC474479
0.6667 Remote Similarity NPC201424
0.6667 Remote Similarity NPC267885
0.6667 Remote Similarity NPC316405
0.6667 Remote Similarity NPC130931
0.6667 Remote Similarity NPC478016
0.6667 Remote Similarity NPC478015
0.6667 Remote Similarity NPC477159
0.6667 Remote Similarity NPC478014
0.6648 Remote Similarity NPC235684
0.6647 Remote Similarity NPC285622
0.6646 Remote Similarity NPC61013
0.6646 Remote Similarity NPC123241
0.6645 Remote Similarity NPC315051
0.6643 Remote Similarity NPC35850
0.6643 Remote Similarity NPC276949
0.6642 Remote Similarity NPC471317
0.6629 Remote Similarity NPC473298
0.6627 Remote Similarity NPC253667
0.6627 Remote Similarity NPC35510
0.6627 Remote Similarity NPC472121
0.6624 Remote Similarity NPC478040
0.6623 Remote Similarity NPC246913
0.6623 Remote Similarity NPC122553
0.6621 Remote Similarity NPC71684
0.6608 Remote Similarity NPC149155
0.6608 Remote Similarity NPC203468
0.6608 Remote Similarity NPC110500
0.6607 Remote Similarity NPC472115
0.6607 Remote Similarity NPC472114
0.6606 Remote Similarity NPC193410
0.66 Remote Similarity NPC187231
0.66 Remote Similarity NPC325651
0.6597 Remote Similarity NPC226143
0.6597 Remote Similarity NPC319950
0.6596 Remote Similarity NPC470550
0.6596 Remote Similarity NPC33742
0.6596 Remote Similarity NPC205652
0.6591 Remote Similarity NPC322598
0.659 Remote Similarity NPC126709
0.659 Remote Similarity NPC248041
0.659 Remote Similarity NPC283219
0.659 Remote Similarity NPC219336
0.6577 Remote Similarity NPC210950
0.6577 Remote Similarity NPC199738
0.6573 Remote Similarity NPC284706
0.6566 Remote Similarity NPC248117
0.6564 Remote Similarity NPC471132
0.6562 Remote Similarity NPC315829
0.6554 Remote Similarity NPC101719
0.6552 Remote Similarity NPC279385
0.6552 Remote Similarity NPC179605
0.6552 Remote Similarity NPC469896
0.6548 Remote Similarity NPC52059
0.6548 Remote Similarity NPC470069
0.6545 Remote Similarity NPC104345
0.6545 Remote Similarity NPC24617
0.6536 Remote Similarity NPC316104
0.6536 Remote Similarity NPC162417
0.6534 Remote Similarity NPC245741
0.6534 Remote Similarity NPC471742
0.6534 Remote Similarity NPC97584
0.6533 Remote Similarity NPC311753
0.6533 Remote Similarity NPC101372
0.6533 Remote Similarity NPC122235
0.6533 Remote Similarity NPC296712
0.6532 Remote Similarity NPC15573
0.6532 Remote Similarity NPC183662
0.6532 Remote Similarity NPC217372
0.6531 Remote Similarity NPC254698
0.6527 Remote Similarity NPC99632
0.6527 Remote Similarity NPC282339
0.6527 Remote Similarity NPC472120
0.6527 Remote Similarity NPC472101
0.6527 Remote Similarity NPC293458
0.6524 Remote Similarity NPC161827
0.6519 Remote Similarity NPC474430
0.6519 Remote Similarity NPC178681
0.6507 Remote Similarity NPC103292
0.6506 Remote Similarity NPC114806
0.6503 Remote Similarity NPC90967
0.65 Remote Similarity NPC146370
0.6497 Remote Similarity NPC468984
0.6494 Remote Similarity NPC475094
0.6494 Remote Similarity NPC218594
0.6494 Remote Similarity NPC99043
0.649 Remote Similarity NPC477432
0.6488 Remote Similarity NPC113056
0.6488 Remote Similarity NPC292143
0.6488 Remote Similarity NPC138293
0.6488 Remote Similarity NPC139506
0.6486 Remote Similarity NPC222466
0.6485 Remote Similarity NPC63370
0.6485 Remote Similarity NPC36836
0.6485 Remote Similarity NPC29285
0.6481 Remote Similarity NPC473329
0.6481 Remote Similarity NPC300443
0.648 Remote Similarity NPC175474
0.6478 Remote Similarity NPC314114
0.6471 Remote Similarity NPC470392
0.6467 Remote Similarity NPC474058
0.6467 Remote Similarity NPC225319
0.6467 Remote Similarity NPC27904
0.6463 Remote Similarity NPC469903
0.6463 Remote Similarity NPC142577

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC287358 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8378 Intermediate Similarity NPD7105 Phase 1
0.8125 Intermediate Similarity NPD181 Approved
0.7987 Intermediate Similarity NPD5982 Phase 2
0.7986 Intermediate Similarity NPD1070 Approved
0.7986 Intermediate Similarity NPD1069 Approved
0.777 Intermediate Similarity NPD2887 Clinical (unspecified phase)
0.7733 Intermediate Similarity NPD5942 Approved
0.7733 Intermediate Similarity NPD5941 Approved
0.7703 Intermediate Similarity NPD3016 Clinical (unspecified phase)
0.766 Intermediate Similarity NPD6359 Clinical (unspecified phase)
0.7635 Intermediate Similarity NPD5024 Approved
0.7517 Intermediate Similarity NPD1071 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1036 Approved
0.75 Intermediate Similarity NPD3625 Discontinued
0.7482 Intermediate Similarity NPD1360 Approved
0.7464 Intermediate Similarity NPD1079 Discontinued
0.7448 Intermediate Similarity NPD5185 Approved
0.7448 Intermediate Similarity NPD5182 Approved
0.7448 Intermediate Similarity NPD5184 Approved
0.7434 Intermediate Similarity NPD1801 Approved
0.7434 Intermediate Similarity NPD1802 Approved
0.7407 Intermediate Similarity NPD1348 Approved
0.7386 Intermediate Similarity NPD4432 Discontinued
0.7378 Intermediate Similarity NPD8022 Clinical (unspecified phase)
0.7343 Intermediate Similarity NPD1781 Discontinued
0.7342 Intermediate Similarity NPD7599 Phase 2
0.7338 Intermediate Similarity NPD5748 Phase 2
0.7324 Intermediate Similarity NPD9540 Approved
0.7296 Intermediate Similarity NPD7600 Phase 2
0.7285 Intermediate Similarity NPD2820 Phase 3
0.7273 Intermediate Similarity NPD1664 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD7528 Approved
0.7267 Intermediate Similarity NPD5430 Discontinued
0.7241 Intermediate Similarity NPD1619 Phase 3
0.7222 Intermediate Similarity NPD766 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD2365 Approved
0.7215 Intermediate Similarity NPD1663 Discontinued
0.7212 Intermediate Similarity NPD5466 Approved
0.7197 Intermediate Similarity NPD2603 Clinical (unspecified phase)
0.7184 Intermediate Similarity NPD7429 Clinical (unspecified phase)
0.7183 Intermediate Similarity NPD9539 Approved
0.7183 Intermediate Similarity NPD9541 Approved
0.7181 Intermediate Similarity NPD4077 Clinical (unspecified phase)
0.7162 Intermediate Similarity NPD1228 Phase 2
0.7161 Intermediate Similarity NPD4161 Discontinued
0.7143 Intermediate Similarity NPD5445 Approved
0.7133 Intermediate Similarity NPD1110 Approved
0.7133 Intermediate Similarity NPD3170 Approved
0.7133 Intermediate Similarity NPD6864 Phase 2
0.7133 Intermediate Similarity NPD6865 Phase 2
0.7133 Intermediate Similarity NPD1109 Approved
0.7123 Intermediate Similarity NPD4738 Phase 2
0.7108 Intermediate Similarity NPD5919 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD6913 Approved
0.7091 Intermediate Similarity NPD4150 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD5086 Approved
0.7086 Intermediate Similarity NPD989 Approved
0.7078 Intermediate Similarity NPD5060 Phase 1
0.7071 Intermediate Similarity NPD4504 Clinical (unspecified phase)
0.7067 Intermediate Similarity NPD2670 Approved
0.7063 Intermediate Similarity NPD212 Discontinued
0.7051 Intermediate Similarity NPD4888 Discontinued
0.7048 Intermediate Similarity NPD7854 Phase 2
0.7047 Intermediate Similarity NPD2470 Clinical (unspecified phase)
0.7045 Intermediate Similarity NPD1040 Phase 2
0.7012 Intermediate Similarity NPD3587 Clinical (unspecified phase)
0.7007 Intermediate Similarity NPD1681 Approved
0.7007 Intermediate Similarity NPD1680 Approved
0.7007 Intermediate Similarity NPD1682 Approved
0.7 Intermediate Similarity NPD2217 Approved
0.7 Intermediate Similarity NPD2218 Phase 2
0.6993 Remote Similarity NPD2584 Suspended
0.6987 Remote Similarity NPD1553 Approved
0.6974 Remote Similarity NPD1209 Approved
0.6974 Remote Similarity NPD1205 Approved
0.6966 Remote Similarity NPD553 Approved
0.6966 Remote Similarity NPD9567 Approved
0.6966 Remote Similarity NPD552 Approved
0.6964 Remote Similarity NPD4091 Approved
0.6963 Remote Similarity NPD1107 Approved
0.6963 Remote Similarity NPD1108 Approved
0.6954 Remote Similarity NPD3096 Phase 2
0.6954 Remote Similarity NPD6294 Approved
0.6954 Remote Similarity NPD6295 Approved
0.6948 Remote Similarity NPD1625 Approved
0.6943 Remote Similarity NPD4682 Phase 2
0.6941 Remote Similarity NPD6833 Clinical (unspecified phase)
0.6939 Remote Similarity NPD2919 Clinical (unspecified phase)
0.6939 Remote Similarity NPD2918 Clinical (unspecified phase)
0.6928 Remote Similarity NPD3434 Clinical (unspecified phase)
0.6923 Remote Similarity NPD3991 Approved
0.6923 Remote Similarity NPD3992 Approved
0.6923 Remote Similarity NPD3995 Approved
0.6923 Remote Similarity NPD3996 Approved
0.6923 Remote Similarity NPD3993 Approved
0.6923 Remote Similarity NPD3994 Approved
0.6923 Remote Similarity NPD4092 Approved
0.6918 Remote Similarity NPD5993 Phase 1
0.6914 Remote Similarity NPD4335 Clinical (unspecified phase)
0.6905 Remote Similarity NPD3522 Approved
0.6901 Remote Similarity NPD9272 Approved
0.6899 Remote Similarity NPD9566 Approved
0.6897 Remote Similarity NPD8103 Clinical (unspecified phase)
0.6882 Remote Similarity NPD3997 Approved
0.6882 Remote Similarity NPD3999 Approved
0.6882 Remote Similarity NPD3998 Approved
0.6875 Remote Similarity NPD5042 Phase 1
0.6859 Remote Similarity NPD4711 Clinical (unspecified phase)
0.6853 Remote Similarity NPD1124 Approved
0.6853 Remote Similarity NPD1123 Approved
0.6846 Remote Similarity NPD5581 Approved
0.6846 Remote Similarity NPD864 Approved
0.6846 Remote Similarity NPD865 Approved
0.6842 Remote Similarity NPD4214 Discontinued
0.6832 Remote Similarity NPD5257 Clinical (unspecified phase)
0.6828 Remote Similarity NPD1640 Clinical (unspecified phase)
0.6818 Remote Similarity NPD2093 Discontinued
0.6813 Remote Similarity NPD1879 Approved
0.68 Remote Similarity NPD1316 Discontinued
0.6797 Remote Similarity NPD1626 Approved
0.6788 Remote Similarity NPD3643 Approved
0.6788 Remote Similarity NPD3642 Approved
0.6788 Remote Similarity NPD3644 Approved
0.6788 Remote Similarity NPD3790 Phase 2
0.6776 Remote Similarity NPD1206 Approved
0.6776 Remote Similarity NPD1207 Approved
0.6774 Remote Similarity NPD1189 Approved
0.6772 Remote Similarity NPD7441 Clinical (unspecified phase)
0.677 Remote Similarity NPD1634 Approved
0.6765 Remote Similarity NPD476 Approved
0.6763 Remote Similarity NPD1373 Approved
0.6763 Remote Similarity NPD1374 Approved
0.6763 Remote Similarity NPD1371 Approved
0.6763 Remote Similarity NPD23 Approved
0.6763 Remote Similarity NPD1370 Approved
0.6761 Remote Similarity NPD922 Approved
0.6759 Remote Similarity NPD5108 Clinical (unspecified phase)
0.6757 Remote Similarity NPD4177 Approved
0.6757 Remote Similarity NPD4175 Approved
0.6753 Remote Similarity NPD4707 Clinical (unspecified phase)
0.6748 Remote Similarity NPD8630 Approved
0.6744 Remote Similarity NPD3989 Phase 3
0.6742 Remote Similarity NPD7570 Approved
0.6742 Remote Similarity NPD7569 Approved
0.6738 Remote Similarity NPD732 Approved
0.6738 Remote Similarity NPD733 Approved
0.6738 Remote Similarity NPD5162 Approved
0.6735 Remote Similarity NPD6302 Clinical (unspecified phase)
0.6735 Remote Similarity NPD3606 Clinical (unspecified phase)
0.6732 Remote Similarity NPD6852 Discontinued
0.6731 Remote Similarity NPD4464 Clinical (unspecified phase)
0.6726 Remote Similarity NPD2369 Discontinued
0.6725 Remote Similarity NPD7587 Clinical (unspecified phase)
0.6712 Remote Similarity NPD4677 Discontinued
0.6711 Remote Similarity NPD2331 Discontinued
0.6708 Remote Similarity NPD1633 Approved
0.6707 Remote Similarity NPD4514 Approved
0.6705 Remote Similarity NPD3990 Phase 3
0.669 Remote Similarity NPD4176 Approved
0.669 Remote Similarity NPD4178 Approved
0.6689 Remote Similarity NPD3137 Clinical (unspecified phase)
0.6688 Remote Similarity NPD12 Approved
0.6688 Remote Similarity NPD4158 Clinical (unspecified phase)
0.6688 Remote Similarity NPD1967 Approved
0.6688 Remote Similarity NPD1968 Approved
0.6688 Remote Similarity NPD699 Approved
0.6688 Remote Similarity NPD697 Approved
0.6688 Remote Similarity NPD700 Approved
0.6688 Remote Similarity NPD13 Approved
0.6687 Remote Similarity NPD2836 Approved
0.6687 Remote Similarity NPD2737 Clinical (unspecified phase)
0.6686 Remote Similarity NPD6557 Phase 2
0.6686 Remote Similarity NPD6163 Clinical (unspecified phase)
0.6667 Remote Similarity NPD2844 Phase 3
0.6667 Remote Similarity NPD1324 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6768 Approved
0.6667 Remote Similarity NPD564 Approved
0.6667 Remote Similarity NPD3136 Phase 2
0.6667 Remote Similarity NPD7794 Clinical (unspecified phase)
0.6667 Remote Similarity NPD2360 Approved
0.6667 Remote Similarity NPD6489 Phase 3
0.6667 Remote Similarity NPD563 Approved
0.6647 Remote Similarity NPD750 Phase 2
0.6647 Remote Similarity NPD7014 Clinical (unspecified phase)
0.6646 Remote Similarity NPD5715 Clinical (unspecified phase)
0.6644 Remote Similarity NPD519 Approved
0.6644 Remote Similarity NPD3072 Approved
0.6644 Remote Similarity NPD3071 Approved
0.6644 Remote Similarity NPD3073 Approved
0.6627 Remote Similarity NPD2350 Clinical (unspecified phase)
0.6625 Remote Similarity NPD979 Approved
0.6624 Remote Similarity NPD6301 Phase 2
0.6623 Remote Similarity NPD5299 Approved
0.6621 Remote Similarity NPD9692 Approved
0.6621 Remote Similarity NPD9693 Approved
0.6608 Remote Similarity NPD482 Approved
0.6597 Remote Similarity NPD5981 Approved
0.6597 Remote Similarity NPD2212 Approved
0.6597 Remote Similarity NPD2210 Approved
0.6592 Remote Similarity NPD5077 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data